Skip to content

Access Pharmaceuticals, Inc.

United StatesFDA applicant, unverified

Devices
2

What Access Pharmaceuticals, Inc. makes

Access Pharmaceuticals, Inc. manufactures PROCTIGARD, a topical barrier device for perianal skin protection, and MUGARD MUCOADHESIVE ORAL WOUND RINSE, a mucous membrane adhesive rinse for oral wound care.

These products are classified as Class II under the FDA and are listed in the 510(k) registry. The company is based in the United States.

AI-generated from registry data, 1 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue2

Newest first, rows 1-2 of 2

  • Proctigard Ref K140558

    Active Regimes: 510(k) Registry: 510(k) Class:—
  • Mugard Mucoadhesive Oral Wound Rinse Ref K062795

    Active Regimes: 510(k) Registry: 510(k) Class:—

Frequently asked questions

How many devices does Access Pharmaceuticals, Inc. have in the registry?

The registry currently lists 2 devices for Access Pharmaceuticals, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Access Pharmaceuticals, Inc.'s devices?

Among its 2 most recently registered devices, Access Pharmaceuticals, Inc. has devices listed in FDA 510(k) (2 devices).

What are the newest devices from Access Pharmaceuticals, Inc. in the registry?

The most recently registered devices listed for Access Pharmaceuticals, Inc. include PROCTIGARD and MUGARD MUCOADHESIVE ORAL WOUND RINSE.

Generated automatically from registry data and not verified by a human reviewer.